Literature DB >> 19504617

Magnifying colonoscopy used to predict disease relapse in patients with quiescent ulcerative colitis.

Chiyuki Watanabe1, Masaaki Sumioka, Tomoki Hiramoto, Ikue Noda, Sayaka Oba, Morihisa Akagi, Mikiya Kitamoto, Hiroyasu Yamada, Masaru Imagawa.   

Abstract

BACKGROUND: Many patients with quiescent ulcerative colitis (UC) experience relapse. However, clinical and conventional colonoscopic signs are inadequate for predicting relapse. This study's aim was to investigate the effectiveness of magnifying colonoscopy in predicting relapse in patients with quiescent UC and to evaluate the association of the findings of magnifying colonoscopy with the histological findings.
METHODS: Magnifying colonoscopy was performed in 57 patients with clinical and endoscopic inactive UC. Patients were divided into 3 groups according to the findings of magnifying colonoscopy as MR (magnify-regular), MI (magnify-irregular), and MD (magnify-defect). Their subsequent clinical course was compared to assess the clinical usefulness of magnifying observation in predicting relapse. We also compared histological findings according to Riley's criteria to each finding of magnifying colonoscopy.
RESULTS: Within 12 months, 1 of 18 patients (6.7%), 10 of 22 patients (45.5%), and 12 of 17 patients (70.6%) with findings of magnifying colonoscopy of MR, MI, and MD, respectively, experienced relapse. The MR group had a significantly low relapse rate compared with the MD and MI groups (P = 0.016, P = 0.002). When histological findings were compared with the findings of magnifying colonoscopy, the mean score of each variable, such as acute inflammatory cell infiltrate, chronic inflammatory cell infiltrate, and crypt architectural irregularities was significantly lower in the MR group than in the MD and MI groups.
CONCLUSIONS: The findings of magnifying colonoscopy in patients with quiescent UC is useful for predicting relapse and is associated with histological grade of inflammation.

Entities:  

Mesh:

Year:  2009        PMID: 19504617     DOI: 10.1002/ibd.20949

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

Review 1.  How to predict clinical relapse in inflammatory bowel disease patients.

Authors:  Elisa Liverani; Eleonora Scaioli; Richard John Digby; Matteo Bellanova; Andrea Belluzzi
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Advanced endoscopic imaging for diagnosis of Crohn's disease.

Authors:  Helmut Neumann; Klaus Mönkemüller; Claudia Günther; Raja Atreya; Michael Vieth; Markus F Neurath
Journal:  Gastroenterol Res Pract       Date:  2011-11-24       Impact factor: 2.260

Review 3.  Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations.

Authors:  Jae Hee Cheon
Journal:  J Pathol Transl Med       Date:  2015-05-15

4.  Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis.

Authors:  Chang-Qing Li; Jun Liu; Rui Ji; Zhen Li; Xiang-Jun Xie; Yan-Qing Li
Journal:  BMC Gastroenterol       Date:  2014-03-11       Impact factor: 3.067

Review 5.  Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?

Authors:  Noor Mohammed; Venkataraman Subramanian
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

6.  Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY).

Authors:  Maxime Dougados; Karsten Kissel; Tom Sheeran; Paul P Tak; Philip G Conaghan; Emilio Martín Mola; Georg Schett; Howard Amital; Federico Navarro-Sarabia; Antony Hou; Corrado Bernasconi; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

7.  Magnifying Endoscopic Findings Can Predict Clinical Outcome during Long-Term Follow-Up of More Than 12 Months in Patients with Ulcerative Colitis.

Authors:  Hajime Isomoto; Ryohei Uehara; Tomayoshi Hayashi; Junya Shiota; Kayoko Matsushima; Chun Chuan Chen; Fuminao Takeshima; Toshiyuki Nakayama; Kazuhiko Nakao
Journal:  Gastroenterol Res Pract       Date:  2013-10-02       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.